Evotec-Bristol Myers Squibb Partnership Hits $25M Milestone in Neurodegenerative Research
Evotec SE has received a $25 million milestone payment from Bristol Myers Squibb, marking further progress in their strategic partnership focused on advancing neuroscience programs.…